Human Papillomavirus Immunisation Programme. Background
|
|
- Milton Morton
- 6 years ago
- Views:
Transcription
1 Human Papillomavirus Immunisation Programme Background Recommending the use of a human papillomavirus (HPV) vaccine was first signalled in the New Zealand Cancer Control Strategy Action Plan Including HPV in New Zealand s Immunisation Schedule was recommended by the Ministry of Health s Immunisation Technical Working Group in November The Ministry s Statement of Intent identified the funding and implementation of a mass HPV immunisation programme as one of two new initiatives. The programme was announced in Budget The development of a highly effective vaccine against the major cancercausing types of HPV was an important opportunity for the primary prevention of cancer in New Zealand. About HPV Over 99 percent of all cervical cancer is linked to HPV infection. While most people clear the virus by themselves, those who have persisting infection can develop precancerous lesions. If the precancerous lesions are not detected by cervical screening and removed, over time they can develop into cervical cancer. HPV also causes genital warts, genital cancers and some mouth and throat cancers. Genital warts are the most commonly reported viral sexually transmitted infection in New Zealand. HPV affects an estimated eighty percent of sexually active women with the peak incidence of infection occurring in women between 16 and 20 years old. Most HPV cases have no symptoms and will clear by themselves. Both cervical cancer incidence and mortality have fallen dramatically in New Zealand (as in other developed countries) over the last decade, due to cervical screening. However approximately 160 New Zealand women are diagnosed with cervical cancer each year and on average 50 women die of the disease each year. In 2004 genital warts were the most commonly reported viral sexually transmitted infection by sexual health clinics in New Zealand, with 4018 new diagnoses in males and females. About the HPV Immunisation Programme Two HPV vaccines are licensed for use in New Zealand (Gardasil and Cervarix ). Both protect against HPV types 16 and 18 which cause 70 percent of cervical cancers. Page 1 of 7
2 Gardasil also protects against the strains of HPV (types 6 and 11) that cause 90 percent of genital warts. HPV vaccine (as Gardasil ) was added to New Zealand s Immunisation Schedule for girls in year 8 at school (or age 12 in primary care) from January There is also a catch-up programme for young women born on or after 1 January 1990 which began on 1 September HPV immunisation is given as three injections over 6 months. The aim of the HPV immunisation programme is to protect young women from HPV infection and the risk of developing cervical cancer later in life. The HPV vaccine does not protect against all types of HPV that can cause cervical cancer. Cervical screening is recommended for all women aged 20 to 70 if they have ever been sexually active. Together, HPV immunisation and screening offer women the best protection against cervical cancer. Eligibility for HPV immunisation Young women born in 1990 and 1991 have until 31 December 2011 and girls born from 1992 onwards have until their 20 th birthday to start the programme. School participation School boards of trustees were given the decision whether to allow the HPV immunisation to be given on their premises. Ninety-five percent of eligible schools have allowed the programme. This excludes schools in the Canterbury District Health Board area where the vaccine is only offered through primary care is the final year of the school-based catch-up programme. From 2011 onwards, HPV immunisation will only be offered through participating schools to girls in year 8, although it will continue to be available through primary care. Uptake Most DHBs phased the offer of HPV vaccine over two years so not all eligible girls were offered the programme in In ,763 girls and young women were eligible to receive HPV vaccine and 53 percent of them received dose 1. The following is a breakdown of the cohorts: 45% of young women born in 1990 and 1991 have started the programme, mainly through primary care. Page 2 of 7
3 59% of girls born between 1992 and 1996 who were offered the immunisation in 2009 have started the programme, mainly through participating schools. Achieving equity As of 25 March 2010, 246,580 girls and young women were eligible for HPV vaccine and 38 percent of them had received dose 1. To date 253,310 doses of HPV vaccine have been given (includes doses 1 to 3). A key achievement in 2009 was the equitable coverage in school-aged girls. Nearly all DHBs have greater coverage for Māori and Pacific girls compared to all. This is significant given the burden of disease experienced by Māori who traditionally have the lowest immunisation rate of any ethnic group and the highest rate of cervical cancer. Population Benefit As cervical cancer develops over 10 to 20 years it will be some time before population-wide benefits are seen in terms of reductions in cervical cancer rates. However, reductions in the number of abnormal smear test results (cervical abnormalities and pre-cancers) and genital wart diagnoses are likely to be seen more quickly. In time, the Ministry of Health expects that HPV immunisation will help halve the number of women in New Zealand who develop cervical cancer. It will also help reduce the incidence of other cancers related to HPV infection, such as vaginal cancer. Potential issues 1. Maintaining public trust and confidence in vaccines generally and HPV specifically. 2. HPV immunisation coverage rates are not maximising the opportunity to reduce the burden of cervical cancer for future generations. Gardasil - Vaccine safety Gardasil was approved for use in New Zealand by Medsafe. The vaccine was considered to have acceptable efficacy quality and safety in accordance with international guidelines and the requirements of the Medicines Act A summary of the known information about Gardasil for health care professionals is contained in the data sheet, published on the Medsafe website ( A similar summary for consumers is also available as a Consumer Medicine Information sheet on the Medsafe website. The documents are updated as necessary. Page 3 of 7
4 Medsafe in conjunction with the Centre for Adverse Reactions Monitoring and Medicines Adverse Reactions Committee continuously reviews the safety of all medicines and vaccines including Gardasil. This monitoring includes analysis of spontaneous reports of suspected adverse reactions to immunisation in New Zealand, Periodic Safety Update Reports provided every six months by the company, published literature and information from other medicines regulators. Periodic Safety Update Reports include: a summary of reported suspected adverse reactions in association with a medicine, an analysis of the reports with actions taken when appropriate, an overview of any regulatory actions taken and exposure data. To date the majority of reactions linked to vaccination with Gardasil and listed in the data sheet are those generally associated with vaccination: injection site reactions, dizziness, fainting, nausea, fever, headache, chills and tiredness. Rare but serious potential adverse reactions associated to Gardasil and listed in the data sheet include: Guillain-Barre syndrome and anaphylaxis. Guillain- Barre syndrome is a rare neurological disease usually caused by viral infection. It has also been associated with seasonal flu vaccines. Anaphylaxis can also occur in response to contact with peanuts and other food items, in some people. If anaphylaxis does occur, it can be treated. This is why people are asked to wait for 15 to 20 minutes after immunisation. Every vaccinator is trained and equipped to deal with such a reaction. Medsafe and its expert advisory committee the Medicines Adverse Reaction Monitoring Committee reviewed the United States Communicable Disease Centre analysis of all spontaneous reports associated with Gardasil in the United States Vaccine Adverse Event Reporting System database published in Both Medsafe and the Medicines Adverse Reaction Monitoring Committee agreed with the author s conclusions that most of the reported event rates for Gardasil were not greater than the background rates seen for other vaccines. There was higher than expected reporting of syncope (fainting) and venous thromboembolic events. The significance of these findings must be tempered with the limitations (possible underreporting) of a passive reporting system. It should be noted that the comparison group of all other vaccines would have largely comprised childhood and adult vaccination rather than adolescent vaccination. Adolescent girls immunised in a school based setting have previously been found to show high rates of fainting and have high rates of initiating oral contraceptive use, a risk factor for thromboembolism. The differences in the comparison groups may be sufficient to account for the study findings. Adverse Event Reports in New Zealand Page 4 of 7
5 The Centre for Adverse Reactions Monitoring reports suspected adverse events reports to Gardasil on a monthly basis to the Ministry of Health. It is important to note that a report of a suspected reaction to a vaccine does not necessarily mean that it has been caused by the vaccine. Healthcare professionals and consumers are encouraged to report any suspicions that an event may have been caused by vaccination. Therefore reports sent to the Centre for Adverse Reactions Monitoring may be: true adverse reactions to the vaccine anxiety events or nervousness about needles or the process of vaccination coincidental and would have occurred anyway. For these reasons summaries of reported events following vaccination are not lists of known or proven adverse reactions to vaccines and must not be interpreted and used as such. Suspected adverse reactions reporting rates are very variable and dependent on many factors. Therefore these data cannot be used to determine the frequency of adverse reactions to vaccines. Summaries of reported events cannot be used to directly compare the relative safety of vaccines. With any vaccine the following types of suspected side effects are expected to be reported. Injection site reactions Well-recognised events such as headaches, dizziness, muscle aches, mild fever and tiredness Mild allergic reactions such as mild rashes and itching. A few serious allergic reactions. Healthcare professionals giving vaccines are trained to spot the symptoms of serious allergic reactions and treat them. Events due to fear or anticipations of the needle injection such as fainting. Coincidental medical conditions New side effects. In New Zealand it is unlikely that rare side effects to vaccines will be detected as the population immunised is usually too small. Therefore Medsafe uses international data to help determine if these rare events may be due to vaccination. Medsafe discusses medicines and vaccine safety issues on a regular basis with other medicines regulatory authorities. At 31 January 2010, 242 suspected adverse events following HPV vaccine had been reported to the Centre for Adverse Reactions Monitoring. Most reports were of minor ailments, like arm pain or swelling, dizziness, nausea and/or vomiting. Reports are defined as serious using the internationally accepted criteria outlined below: Page 5 of 7
6 Results in death Is life-threatening Requires inpatient hospitalisation or prolongation of existing hospitalisation Results in persistent or significant disability/incapacity Requires intervention to prevent permanent disability/ incapacity Results in a congenital anomaly In addition to internationally accepted criteria the Centre for Adverse Reactions Monitoring have also considered that cases where the patient attended an Emergency Department or after-hours clinic to be serious. Using the above criteria 31 of the 242 reports were considered to be serious. Table 1: An overview of 31 adverse event reports considered serious to 31 January 2010 Number of reports Death 1 Life-threatening 1 Intervention required 1 Hospitalisation 4 Persisting disability 4 Emergency department attendance 20 In summary these serious cases comprised: One report of sudden death, six months after the final vaccination. The case has been investigated by CARM and Medsafe and the cause of death is currently undetermined. This case is before the Coroner. A single life threatening report of severe hypersensitivity reaction involving tongue swelling. An intervention report describing an injection site abscess that required surgical draining. Four reports of hospitalisation: o systemic symptoms including diabetes and eye problems, both of which had been diagnosed prior to vaccination o convulsions two weeks following vaccination o fainting episode resulting in overnight observation o Leukaemia reported; not attributed to vaccination. Four reports of persisting symptoms: o three reports describe general symptoms of muscle aches, headache and fatigue Page 6 of 7
7 o one report of hair loss 20 reports of emergency department attendance including: o nine reports of syncope (fainting) o seven reports of allergic-type symptoms such as rash o two reports of convulsion-like episodes, occurring immediately following immunisation and lasting longer than usually observed with a faint. o one report of severe arm pain and swelling o one report of Bell's Palsy (face paralysis) starting within one day of vaccination that may have been due to a recent infection. The Ministry of Health concludes on the basis of current evidence, both local and international, that the benefits of HPV vaccination continue to outweigh possible risks. Page 7 of 7
Immunise against HPV
Immunise against HPV (Human Papillomavirus) Helps prevent cancers caused by HPV infection Information for young people and their families and whānau Human papillomavirus (HPV) immunisation helps protect
More informationHPV Vaccine (Human Papillomavirus Vaccine)
HPV Vaccine (Human Papillomavirus Vaccine) Helps prevent cancers caused by HPV infection Parent Consent Form Please sign and return the form to school. COOK ISLANDS MĀORI SAMOAN TONGAN MĀORI ENGLISH HPV
More informationQuestions and answers about HPV. Facts about the virus and the vaccine
Questions and answers about HPV Facts about the virus and the vaccine About the introduction of the human papillomavirus (HPV) vaccine Which countries have introduced the HPV vaccine? Over 100 countries
More informationYour guide to the HPV vaccine
Your guide to the HPV vaccine This leaflet gives you information about the human papillomavirus (HPV) vaccine offered to all girls in school year 8 to protect against cervical cancer. This leaflet explains
More informationThe HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland
The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland Immunisations Very cost effective intervention Give vaccine before exposure to disease UK has life course approach
More informationApril Blackmon NURS7440/7550. Gardasil. Auburn University/Auburn Montgomery
April Blackmon Health Promotion Paper NURS7440/7550 Gardasil Auburn University/Auburn Montgomery 2 Introduction Human papillomavirus or HPV is a virus that will affect an estimated 75%- 80% of males and
More informationFacts about HPV vaccine
Facts about HPV vaccine www.hpv.ie Many parents are reading and hearing lots of scare stories about HPV vaccine. Gardasil HPV vaccine is safe and effective. Please read the facts below 1. Every year in
More informationHPV doesn t concern men?
Think HPV doesn t concern men? What you should know about HPV-related cancers and genital warts. One infected partner may be all it takes to get HPV. HPV=human papillomavirus Trying to decide if GARDASIL
More informationPreventing human papillomavirus (HPV) cancers and diseases by vaccination
Preventing human papillomavirus (HPV) cancers and diseases by vaccination Helping to protect young people from a range of cancers and diseases caused by the human papillomavirus (HPV) health.gov.au/immunisation
More informationThe HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health
The HPV Immunisation Programme in NZ Chris Millar Senior Advisor Immunisation Ministry of Health chris_millar@moh.govt.nz 4 September 2015 Background of NZ s HPV Immunisation Programme Aim: To protect
More informationBeating cervical cancer
Beating cervical cancer The HPV vaccine questions and answers for parents of girls in Year 9 and 10 This Q&A on the HPV vaccine supports the leaflet that your daughter should have been given at school.
More informationEvery Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates
Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates Lorraine Glover [Immunisation Nurse Consultant] HUMAN PAPILLOMA VIRUS
More informationGARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information
GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available
More informationImmunisation in the Bay of Plenty and Lakes
Medical Officer of Health Report August 2017 Immunisation in the Bay of Plenty and Lakes The New Zealand Immunisation Schedule The current New Zealand vaccination schedule protects against the illnesses
More informationThe National Immunisation Schedule. Dr Brenda Corcoran.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake
More informationHPV WHAT YOU SHOULD KNOW ABOUT HPV, CERVICAL CANCER, AND GENITAL WARTS. CERVICAL CANCER IS CAUSED BY CERTAIN TYPES OF A VIRUS.
WHAT YOU SHOULD KNOW ABOUT HPV, CERVICAL CANCER, AND GENITAL WARTS. CERVICAL CANCER IS CAUSED BY CERTAIN TYPES OF A VIRUS. Cervical cancer is cancer of the cervix (the lower part of the uterus that connects
More informationTraining for Inactivated Poliovirus Vaccine (IPV) introduction. Module 6. Inactivated poliovirus vaccine AEFI monitoring
Training for Inactivated Poliovirus Vaccine (IPV) introduction Module 6 Inactivated poliovirus vaccine AEFI monitoring Learning objectives At the end of the module, the participants will be able to: Identify
More informationFACT CHECK ABOUT HPV VACCINE AND CERVICAL CANCER
FACT CHECK ABOUT HPV VACCINE AND CERVICAL CANCER Dear Parents and Guardians, the HSE leaflet that accompanies the consent form for the HPV vaccine makes a number of statements designed to alleviate your
More informationDepartment of Health. Year 8. vaccination program. Important information for parents and students
Department of Health Year 8 vaccination program Important information for parents and students Contents Why immunise? 1 Vaccination program 1 Schedule of vaccinations 2 Vaccination records 2 Vaccine safety
More informationThe national human papillomavirus (HPV) vaccination programme - the move to two-dose schedule
The national human papillomavirus (HPV) vaccination programme - the move to two-dose schedule An update for registered healthcare practitioners August 2014 Quality Education for a Healthier Scotland 1
More informationGARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant
SWISS SUMMARY OF ACTIVITIES IN THE RISK MANAGEMENT PLAN FOR GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant Active Substance: Human Papillomavirus 9-valent Vaccine, Recombinant MAH / MAA
More informationThe National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office www.immunisation.ie Objectives To outline immunisation schedules in Ireland Primary childhood
More informationThe National Immunisation Schedule. Dr Brenda Corcoran.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office www.immunisation.ie Objectives To outline key issues in immunisation Primary childhood immunisation
More informationFree human papillomavirus (HPV) and hepatitis A and hepatitis B vaccines
Free human papillomavirus (HPV) and hepatitis A and hepatitis B vaccines for children in Grade 4 of primary school Vaccination, the best protection Form to complete inside Vaccination This leaflet contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Gardasil, suspension for injection in a pre-filled syringe Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed) Read all of this leaflet
More informationINFLUENZA 2009 H1N1. INACTIVATED (the flu shot ) W H A T Y O U N E E D T O K N O W. 1 What is 2009 H1N1 influenza? H1N1 influenza vaccine
2009 H1N1 INFLUENZA INACTIVATED (the flu shot ) VACCINE W H A T Y O U N E E D T O K N O W Many Vaccine Information Statements are available in Spanish and other languages. See http://www.immunize.org/vis.
More informationMedia Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) (908)
News Release Media Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) 652-0059 (908) 423-5185 Janet Skidmore (267) 305-7715 Merck Launches National Advertising Campaign for GARDASIL, Merck's
More informationHuman Papillomavirus Lafayette Medical Education Foundation June 19, 2018
Human Papillomavirus Lafayette Medical Education Foundation June 19, 2018 Katherine McHugh, MD Indiana University Dept. of OB/GYN kwmchugh@iupui.edu Take Home Points: - Risk factors for HPV infection:
More informationYou are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Successfully Communicating about HPV Vaccination Disclosure This
More informationImmunizations Offered
Immunizations Offered Most vaccines commercially available in the United States are available at the health clinic. A partial list of available vaccines follows. For more information about specific vaccines
More informationMake the CASE FOR PHARMACISTS ONLY. Helpful information for talking to parents about HPV vaccination
FOR PHARMACISTS ONLY Make the CASE Helpful information for talking to parents about HPV vaccination Indication GARDASIL 9 is a vaccine indicated in females 9 through 26 years of age for the prevention
More informationRecommended vaccines in the United States. Maki Kano, MD September 23, 2017 Apple Time
Recommended vaccines in the United States Maki Kano, MD September 23, 2017 Apple Time Recommended Vaccines 0 to 6 years old Recommended Vaccines 7 to 18 Vaccine schedule in Japan Vaccines in Japan Routine
More informationHPV Frequently Asked Questions (FAQs) for an Adolescent Audience. Geneva Philips Pan American Health Organization
HPV Frequently Asked Questions (FAQs) for an Adolescent Audience Geneva Philips Pan American Health Organization Importance of HPV FAQs for an Adolescent Audience Combats HPV knowledge gap Offers basic,
More informationWednesday, March 16, 2016
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Bea Himmelwright-Lamm, EdD, RN
More informationAuthorization for vaccination
FOR USE BY CLSC INFORMATION RELATING TO VACCINATION Free Vaccination programs File no FIRST dose in grade 4 elementary school CONTRAINDICATION TO VACCINATION (specify) You must fill out the vaccination
More informationWe ll be our own lifesavers. We ll get the flu vaccine.
We ll be our own lifesavers. We ll get the flu vaccine. The flu vaccine is a lifesaver for older people and those with long-term health conditions. www.immunisation.ie Flu Vaccine 2017-18 What is seasonal
More informationGuard Ur Self: HPV and Immunization Education
Guard Ur Self: HPV and Immunization Education MOLLY BE N NIN G, MARCU S G ARCIA, JACQUE LY N SILVE R THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ASHP-SSHP Objectives- Pharmacists 1. Review ACIP updates
More informationYear 7 immunisation. Parent Consent Form
Year 7 immunisation Boostrix an immunisation to boost your child's protection against tetanus, diphtheria and whooping cough (pertussis) Parent Consent Form Please sign and return the form to school. COOK
More information9/11/2018. HPV Yoga. Human Papillomavirus. Human Papillomavirus (HPV) Disease. Most common sexually transmitted infection in the U.S.
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Human Papillomavirus September 2018 Chapter 11 Photographs and images included in this presentation
More informationContinuous Professional Education Programme for Registered Nurses and Midwives to Administer Gardasil Vaccine
Continuous Professional Education Programme for Registered Nurses and Midwives to Administer Gardasil Vaccine Under the Medicine Protocol to Girls in Second Level Schools (or equivalent) through a Schools
More informationH1N1 and Flu Shots During Pregnancy
H1N1 and Flu Shots During Pregnancy HEALTH EDUCATION HEALTH EDUCATION The H1N1 flu and seasonal vaccines are safe and recommended for pregnant women. Be sure to: Get the H1N1 flu vaccine for yourself and
More informationThe HPV Vaccine: A Sheep in Wolf's Clothing
The HPV Vaccine: A sheep in wolf s clothing Jessica Francis, MD Medical College of Wisconsin Nothing to disclose Disclosures Objectives To review the effects of HPV To review recommendations regarding
More informationHPV/Cervical Cancer Resource Guide for patients and providers
DHS: PUBLIC HEALTH DIVISION IMMUNIZATION PROGRAM HPV/Cervical Cancer Resource Guide for patients and providers Independent. Healthy. Safe. Oregon HPV Provider Resource Kit: Table of Contents Provider Information
More informationExpanded Eligibility for Human Papillomavirus (HPV) Vaccination for Select Male Populations Q&A Document August 2015
Expanded Eligibility for Human Papillomavirus (HPV) Vaccination for Select Male Populations Q&A Document August 2015 1. Can you tell me more about the expanded eligibility criteria for HPV vaccination?
More informationQuestions and answers about HPV vaccination. Information for parents and caregivers
Questions and answers about HPV vaccination Information for parents and caregivers About the Human papillomavirus (HPV) What is HPV? HPV stands for human papillomavirus. This is a group of viruses that
More informationYour guide to the HPV vaccination. Beating Cervical Cancer
Your guide to the HPV vaccination Beating Cervical Cancer What is cervical cancer? Cervical cancer occurs in the cervix (the entrance to the womb) which is found at the top of the vagina. Cervical cancer
More informationaddressing low uptake
The HPV vaccination programme: addressing low uptake Approximately 200 women develop cervical cancer in New Zealand each year. High-risk strains of human papillomavirus (HPV) is linked to more than 99%
More informationPertussis immunisation for pregnant women
Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction
More informationUniversity Health Services at CMU STI Awareness Month specials for students:
University Health Services at CMU STI Awareness Month specials for students: -Free condoms during April (10 per student) -Free walk-in rapid HIV testing April 22-27 (no appointment needed) -STI Screening
More informationSAGE evidence to recommendations framework i
SAGE evidence to recommendations framework i Question: In 9 to 15-year old females, is 9-valent human papillomavirus vaccine (HPV) vaccine superior to 4-valent or 2-valent HPV vaccines? Population: 9 to
More informationImmunise your child on time. It s their best protection
Immunise your child on time It s their best protection If you are a parent or caregiver, this pamphlet is for you. It tells you about the recommended ages for your baby to receive their immunisations.
More informationQuick Study: Sexually Transmitted Infections
Quick Study: Sexually Transmitted Infections Gonorrhea What is it: A bacterial infection of the genitals, anus, or throat. How common: The CDC estimates 820,000 people in the United States get Gonorrhea
More informationVaccination Policy. Background: Meningococcal Disease on Campus
Vaccination Policy EDMC institutions shall recognize all state and federal vaccination and immunization requirements. Institutions, with the support of EDMC regulatory affairs and compliance and legal
More informationImmunisation for pre-school children. three years and four months old
Immunisation for pre-school children three years and four months old Introduction This leaflet contains the facts about the diphtheria, tetanus, pertussis and polio booster vaccine, and the second MMR
More informationYou are the Key to HPV Cancer Prevention
AHEC Logo here You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about HPV Vaccination Aubrey Stetter-Hesselberg,
More informationEvidence-Based HPV Disease Prevention HPV VACCINE
Evidence-Based HPV Disease Prevention HPV VACCINE Educating and normalizing vaccine compliance for the teen population Leisha Nolen, MD PhD Enroll in Electronic Poll System In the texting app in your phone:
More informationGrade 6 Immunization Package
Grade 6 Immunization Package Grade 6 Immunizations - Fact Sheet Vaccines have saved more lives in Canada in the last 60 years than any other medical intervention. Vaccines help your immune system to recognize
More informationWhat You Should Know. Exploring the Link between HPV and Cancer.
What You Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a virus
More informationHPV facts about the virus, the vaccine and what this means for you. Answers to common questions asked by adolescents and young adults
HPV facts about the virus, the vaccine and what this means for you Answers to common questions asked by adolescents and young adults HPV and vaccination What is HPV and why should I be vaccinated against
More informationIMMUNIZATION POLICY ACKNOWLEDGMENT ARCHDIOCESE OF WASHINGTON Catholic Schools
IMMUNIZATION POLICY ACKNOWLEDGMENT Catholic Schools FORM 5 ALL PARENTS OF STUDENTS ATTENDING ARCHDIOCESAN CATHOLIC SCHOOLS IN THE DISTRICT OF COLUMBIA MUST READ THIS FORM, SIGN BELOW, AND RETURN IT TO
More informationflu vaccination DRAFT The WINTER 2018/19 Who should have it and why Includes information for children and pregnant women mmunisation
flu vaccination Who should have it and why The WINTER 2018/19 Includes information for children and pregnant women The flu vaccination 1 Winter 2018/19 Flu mmunisation Helping to protect everyone, every
More informationGrade 7 School Immunization Program
Grade 7 School Immunization Program Information for Parents/Guardians 1 READ the information booklet about Grade 7 vaccines. 2 COMPLETE the consent form in this package. 3 RETURN the signed form to your
More informationUnadjuvanted H1N Influenza Vaccine Fact Sheet for Pregnant Women
1 of 5 Unadjuvanted H1N1-2009 Influenza Vaccine Fact Sheet for Pregnant Women This fact sheet provides basic information only. It must not take the place of medical advice, diagnosis or treatment. Always
More informationImmunisations at secondary school Your questions answered
Immunisations at secondary school Your questions answered about the HPV and Td/IPV vaccinations given between 12 and 18 years of age (school years 8 to 13) the safest way to protect your health Introduction
More informationflu vaccination The Who should have it and why WINTER 2017/18 Includes information for children and pregnant women mmunisation in England in 2017/18
flu WINTER 2017/18 The vaccination Who should have it and why Includes information for children and pregnant women Flu mmunisation in England in 2017/18 The flu vaccination 1 Winter 2017/18 Helping to
More informationInfluenza Vaccine Fact Sheet 2010/2011
Influenza Vaccine Fact Sheet 2010/2011 This fact sheet provides basic information only. It must not take the place of medical advice, diagnosis or treatment. Always talk to a healthcare professional about
More informationHUMAN PAPILLOMAVIRUS VACCINES AND CERVICAL CANCER
HUMAN PAPILLOMAVIRUS VACCINES AND CERVICAL CANCER Virology The Human Papillomavirus (HPV) is a relatively small virus, belonging to the family Papillomaviridae, containing circular double-stranded DNA
More informationSHOTS! THE GET. Facts About HPV and Meningitis
GET THE SHOTS! Facts About HPV and Meningitis HUMAN PAPILLOMAVIRUS What is HPV? You may have heard a lot of talk recently about HPV. But what is it, exactly? HPV, or the human papillomavirus, is the most
More informationb de HPV Vaccination of School-Age Girls comparing the cost-effectiveness of 3 delivery programmes SUMMARY
b de HPV Vaccination of School-Age Girls comparing the cost-effectiveness of 3 delivery programmes SUMMARY Human papillomaviruses (HPV) are common sexually transmitted viruses. They can cause several types
More informationHPV Immunisation Statistics Scotland
HPV Immunisation Statistics Scotland School Year 2017/18 27 November 2018 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics status means that
More informationswine flu vaccination:
swine flu vaccination: information for parents of children over six months and under five years old Flu. Protect yourself and others. Contents About this leaflet......................... 3 What is swine
More informationflu vaccination The Who should have it and why WINTER 2017/18
The flu vaccination WINTER 2017/18 Who should have it and why At North West Ambulance Service, we re here to support you to stay well this coming winter. This leaflet explains how you can help protect
More informationVaccine Hesitancy- Current Issues and Controversies including HPV vaccine. Dr Brenda Corcoran National Immunisation Office
Vaccine Hesitancy- Current Issues and Controversies including HPV vaccine Dr Brenda Corcoran National Immunisation Office What is vaccine hesitancy? An expression of concern or doubt about the value or
More informationCervical Screening. What Pacific women need to know
Cervical Screening What Pacific women need to know To avoid cervical cancer and to stay well, Pacific women aged from 20 until they turn 70 need to have smear tests every three years. The smear tests look
More informationHPV is the most common sexually transmitted infection in the world.
Hi. I m Kristina Dahlstrom, an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. My lecture today will be on the epidemiology of oropharyngeal
More information11 Year Well Check. Please fill these forms out and bring them to the appointment with you.
11 Year Well Check Forms Included in this packet: 1) Menactra Vaccine Information Sheet 2) Tdap Vaccine Information Sheet 3) HPV Vaccine Information Sheet 4) Immunization Questionnaire 5) Vaccines For
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale
More informationSummary of adverse drug reaction reports in Sweden with Pandemrix (received up to...
Page 1 sur 5 Home / All news / Summary of adverse drug reaction reports in Sweden with Pandemrix (received up to November 10) Thursday, November 12, 2009 As of today, about 2.1 million doses of Pandemrix
More informationMeasles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health
Measles Elimination in NZ Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Presentation Outline International background WHO requirements Overview of the measles situation
More informationNorovirus in Healthcare Settings
ST. JAMES HEALTHCARE DECEMBER 2012 INFECTION PREVENTION NEWSLETTER INSIDE THIS ISSUE: Norovirus in Healthcare Settings The Impacts of Unsafe Medical Injections in the U.S. Preparing Your Skin Before Surgery:
More informationHPV and Cervical Cancer: Current Practice Update
HPV and Cervical Cancer: Current Practice Update Dr. Sheona Mitchell-Foster MD MPH FRCSC Assistant Professor University of British Columbia Fertility and Reproductive Medicine Symposium Disclosures None
More informationVaccine administration. Dr Brenda Corcoran National Immunisation Office
Vaccine administration Dr Brenda Corcoran National Immunisation Office School immunisation programme Workshop 21 st April 2015 Overview Contraindications/ Precautions Adverse events 4 in 1 vaccine HPV
More informationTruth THE STORY OF HIV/ CONSEQUENCE. Women's Ministries Department General Conference of Seventh-day Adventists
Truth OR CONSEQUENCE THE STORY OF HIV/ AIDS Women's Ministries Department General Conference of Seventh-day Adventists What is? HIV (Human Immunodeficiency Virus) is a virus that causes AIDS (Acquired
More informationThe schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008
Immunisations and vaccinations Immunisation is an effective public health intervention for promoting good health and protecting individuals and populations against serious disease and infection through
More informationHelp keep hepatitis A and B out of your travel plans.
Help keep hepatitis A and B out of your travel plans. Hepatitis A and B: Facts for Canadian travellers. Many common travel activities may put travellers at risk for hepatitis A and B. Hepatitis A and B
More informationWHAT IS THE HPV VACCINE?
HPV infection and HPV-associated cervical cancer are significant national and global public health concerns. An estimated 11,000 newly diagnosed cases of cervical cancer occur annually in the United States,
More information2017 Human Papillomavirus Immunisation Programme
2017 Human Papillomavirus Immunisation Programme 1 1 HPV infection HPV is a virus that infects the skin and mucous membranes Most infections clear within 18 months Clearing infection does not confer immunity
More informationYukon School Immunization Program Grade 6 INFORMATION FOR PARENTS/GUARDIANS
Yukon School Immunization Program Grade 6 INFORMATION FOR PARENTS/GUARDIANS July 2018 Read the information in this booklet. Complete, sign and return the Immunization Consent Form that came with this booklet.
More informationClassification: official 1
NHS public health functions agreement 2018-19 Service specification No.4 Immunisation against diphtheria, tetanus, poliomyelitis, pertussis, Hib and HepB programme 1 NHS public health functions agreement
More informationSexually Transmitted. Diseases
Sexually Transmitted Diseases How can I get an STD? Many STDs are carried and transmitted through semen and vaginal fluids. Some STDs can be spread through skin to skin contact Mother to child STDs: Signs
More informationSummary of the risk management plan (RMP) for Spectrila (asparaginase)
EMA/829066/2015 Summary of the risk management plan (RMP) for Spectrila (asparaginase) This is a summary of the risk management plan (RMP) for Spectrila, which details the measures to be taken in order
More informationHPV vaccine the global perspective
National Immunisation Conference Dublin, 25 May 2018 HPV vaccine the global perspective Robb Butler Vaccine-preventable Diseases and Immunization WHO Regional Office for Europe Presentation outline Burden
More informationImmunisation for Older People. Free vaccines to protect against influenza, shingles, tetanus and diphtheria
Immunisation for Older People Free vaccines to protect against influenza, shingles, tetanus and diphtheria This leaflet explains the vaccinations that are recommended and free for older people. As you
More informationMeningococcal. Disease. Know the. symptoms. Don t wait talk to your doctor or nurse
Meningococcal Disease Know the symptoms Don t wait talk to your doctor or nurse Meningococcal disease Meningococcal disease is an infection caused by a bacteria, and can lead to two very serious illnesses:
More informationMidland infectious disease activity summary (MIDAS), Vol 1 (9), Oct 09
Midland infectious disease activity summary (MIDAS), Vol 1 (9), Oct 09 Item Type Other Authors Health Service Executive (HSE) Dublin/Mid-Leinster (Midlands), Publisher Health Service Executive (HSE) Dublin/Mid-Leinster
More informationSUMMARY TABLE OF SEXUALLY TRANSMITTED INFECTIONS
1 of 5 SUMMARY TABLE OF SEXUALLY TRANSMITTED INFECTIONS Sexually Transmitted Infections How is it spread? How do I get tested? Can it be cured? fertility? pregnancy? a newborn? Can the mother breastfeed
More informationImmunisation for Older People
Immunisation for Older People Large Print Copy Free vaccines to protect against influenza, shingles, tetanus and diphtheria. This leaflet explains the vaccinations that are recommended and free for older
More information